Innovid Corp.

NYSE:CTV

3.1 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 38.25137.95136.73838.61736.23434.54630.48533.69834.46933.08825.86225.967-4.47722.84218.01323.02918.59313.43613.743
Cost of Revenue 8.9179.09711.35612.7098.4288.5918.2658.3768.5347.3516.3445.3670.0533.9683.8623.8212.8492.5633.132
Gross Profit 29.33428.85425.38225.90827.80625.95522.2225.32225.93525.73719.51820.6-4.5318.87414.15119.20815.74410.87310.611
Gross Profit Ratio 0.7670.760.6910.6710.7670.7510.7290.7510.7520.7780.7550.7931.0120.8260.7860.8340.8470.8090.772
Reseach & Development Expenses 7.0217.3046.3216.3996.4866.8767.1176.8427.3129.717.3297.687-1.3516.1315.2974.614.2534.5344.886
General & Administrative Expenses 9.2389.29710.53510.7599.7538.9249.658.6889.0469.95511.46610.0932.3664.22.3912.5991.6951.7362.191
Selling & Marketing Expenses 11.68212.21511.62611.29911.17511.4611.63711.86913.72614.3210.529.522-5.2768.1056.6516.1866.9757.2148.435
SG&A 20.9221.51222.16122.05820.92820.38421.28720.55722.77224.27521.98619.615-2.9112.3059.0428.7858.678.9510.626
Other Expenses 000-2.03002.032.6621.8820.9260000007000
Operating Expenses 27.94128.81628.48228.45727.41429.32430.43430.06131.96634.91129.31527.302-4.26118.58514.33913.49113.18313.46415.582
Operating Income 1.393-2.793-3.1-2.5490.392-17.872-8.214-4.739-6.031-9.174-9.797-6.702-0.2690.289-0.1885.8132.821-2.611-4.901
Operating Income Ratio 0.036-0.074-0.084-0.0660.011-0.517-0.269-0.141-0.175-0.277-0.379-0.2580.060.013-0.010.2520.152-0.194-0.357
Total Other Income Expenses Net -1.6780.0780.0420.407-1.71-14.2552.4752.146-4.96213.3062.311-0.508-2.301-1.602-1.569-0.206-0.175-0.253-0.1
Income Before Tax -0.285-2.715-3.058-2.142-4.032-17.624-5.739-2.046-10.9934.132-7.486-7.21-3.413-1.313-1.7575.6072.646-2.864-5.001
Income Before Tax Ratio -0.007-0.072-0.083-0.055-0.111-0.51-0.188-0.061-0.3190.125-0.289-0.2780.762-0.057-0.0980.2430.142-0.213-0.364
Income Tax Expense -4.957.8273.176-0.4843.1231.3352.8241.3830.839-0.168-0.0370.408-0.3710.3460.1790.3010.1780.3790.342
Net Income -0.285-10.542-6.234-1.658-2.731-18.959-8.563-3.429-11.8324.3-7.449-7.618-3.042-1.659-1.9361.882-0.955-1.941-7.095
Net Income Ratio -0.007-0.278-0.17-0.043-0.075-0.549-0.281-0.102-0.3430.13-0.288-0.2930.679-0.073-0.1070.082-0.051-0.144-0.516
EPS 0.032-0.073-0.044-0.012-0.02-0.14-0.063-0.026-0.0890.031-0.06-0.14-0.026-0.014-0.0160.067-0.08-0.16-0.59
EPS Diluted 0.031-0.073-0.044-0.012-0.02-0.14-0.063-0.026-0.0890.031-0.06-0.14-0.026-0.014-0.0160.067-0.08-0.16-0.59
EBITDA 1.3930.038-0.4341.6390.392-1.305-5.87-2.077-4.149-8.248-9.124-6.528-0.1130.438-0.0066.0682.998-2.484-4.73
EBITDA Ratio 0.0360.001-0.0130.0420.1410.382-0.203-0.062-0.12-0.249-0.353-0.2510.0250.019-00.2630.161-0.185-0.344